Team Europe Support Structure (TESS) for Manufacturing and Access to Vaccines, medicines and health technology products in Africa (MAV+)
TESS MAV+
Belgium
| Project summary | |
|
The Action’s overall objective is contributing to the TEI MAV+ that aims to facilitate equitable access to safe, effective, quality and affordable essential vaccines, medicines and health technologies for all Africans. This objective pursues SDG 3.8 and promotes ultimately universal health coverage (UHC). Its attainment requires reinforcing African pharmaceutical systems and the regional manufacturing capacity. |
|
| Code | BEL21003 |
| Start date | 21 December 2022 |
| End date | 31 December 2025 |
| Stage | Execution |
| Donor | European Union |
| Sector | 12110 Health policy and administrative management |
| Budget | Not available |
General objective
To contribute the TEI MAV+ that aims to facilitate equitable access to safe, effective, quality and affordable essential vaccines, medicines and health technologies for all Africans
Specific objective
A - Enhance TEI MAV+ coordination, technical expertise, progress monitoring and communication.
News
No news